Retromer dysfunction in amyotrophic lateral sclerosis

Area of Science:

• Molecular Biology
• Neuroscience
• Cell Biology

Background:

• Retromer is a crucial protein complex involved in endosomal sorting and trafficking.
• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
• Dysregulation of protein trafficking pathways is implicated in neurodegenerative disorders.

Purpose of the Study:

• To investigate the role of retromer components in amyotrophic lateral sclerosis (ALS).
• To determine the impact of retromer alterations on disease progression in an ALS mouse model.
• To explore therapeutic strategies targeting retromer function in ALS.

Main Methods:

• Quantification of retromer proteins (VPS35, VPS26A, VPS29) in human ALS patients and a transgenic mouse model (Tg SOD1^G93A).
• Assessment of GluA1 receptor subunit levels as a functional marker of retromer activity in mouse spinal cords.
• In vivo manipulation of VPS35 levels using viral vectors in Tg SOD1^G93A mice to evaluate disease phenotype.

Main Results:

• Reduced levels of VPS35, VPS26A, and VPS29 were observed in ALS patients and Tg SOD1^G93A mice.
• A decrease in GluA1 levels correlated with retromer deficits in the spinal cords of Tg SOD1^G93A mice.
• Overexpression of VPS35 exacerbated ALS phenotype, while reducing VPS35 levels ameliorated disease progression in mice.

Conclusions:

• Mild alterations in retromer function inversely modulate neurodegeneration in ALS.
• Retromer complex integrity and function are critical in the context of ALS pathogenesis.
• Targeting retromer pathways may offer a novel therapeutic approach for ALS.